Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
Karuna Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Karuna Therapeutics reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, four executives at Karuna Therapeutics received on average a compensation package of $3.4M, a 360% increase compared to previous year.
Average pay of disclosed executives at Karuna Therapeutics
Steven Paul, Chief Executive Officer, received $10M in total, which increased by 932% compared to 2018. 91% of Paul's compensation, or $9.2M, was in option awards. Paul also received $390K in non-equity incentive plan, $495K in salary, as well as $8.4K in other compensation.
Andrew Miller, Chief Operating Officer, received a compensation package of $1.4M, which increased by 152% compared to previous year. 48% of the compensation package, or $698K, was in option awards.
Stephen Brannan, Chief Medical Officer, earned $1M in 2019, a 59% increase compared to previous year.
Troy Ignelzi, Chief Financial Officer, received $942K in 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2020.